Inventor
PESTEL SABINE
DE22 patents
⚠️ This page may combine multiple inventors who share the name “PESTEL SABINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
13 patentsUS7056916B2Jun 6, 2006
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA43 citations96
US6951888B2Oct 4, 2005
Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA22 citations92
US6790856B2Sep 14, 2004
Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
BOEHRINGER INGELHEIM PHARMA17 citations92
US6696462B2Feb 24, 2004
Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA37 citations92
US7727984B2Jun 1, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA9 citations84
US7135500B2Nov 14, 2006
Dihydroxymethylphenyl derivatives, processes for preparing them, and their use as pharmaceuticals
BOEHRINGER INGELHEIM PHARMA16 citations83
US7786111B2Aug 31, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA5 citations73
US6998406B2Feb 14, 2006
Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
BOEHRINGER INGELHEIM PHARMA4 citations73
US6815452B2Nov 9, 2004
Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
BOEHRINGER INGELHEIM PHARMA4 citations73
US7214797B2May 8, 2007
Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
BOEHRINGER INGELHEIM PHARMA4 citations72
US8044046B2Oct 25, 2011
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA2 citations62
US7405224B2Jul 29, 2008
Xanthenecarboxylates, processes for preparing them, and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA0 citations51
US7429600B2Sep 30, 2008
Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
BOEHRINGER INGELHEIM PHARMA0 citations50
CSL Behring Lengnau AG
8 patentsUS10688157B2Jun 23, 2020
Truncated von Willebrand factor polypeptides for treating hemophilia
CSL Behring Lengnau AG2 citations72
US10905747B2Feb 2, 2021
Methods for preparing modified von Willebrand factor
CSL Behring Lengnau AG1 citations68
US11155601B2Oct 26, 2021
Modified von Willebrand factor having improved half-life
CSL Behring Lengnau AG0 citations60
US11564976B2Jan 31, 2023
Methods for preparing modified von Willebrand Factor
CSL Behring Lengnau AG0 citations58
US11141466B2Oct 12, 2021
Modulation of FVIII immunogenicity by truncated VWF
CSL Behring Lengnau AG0 citations57
US11814421B2Nov 14, 2023
Truncated von Willebrand Factor polypeptides for treating hemophilia
CSL Behring Lengnau AG0 citations50
US10772936B2Sep 15, 2020
Methods for preparing modified von Willebrand factor
CSL Behring Lengnau AG0 citations48
US11890327B2Feb 6, 2024
Truncated von Willebrand factor polypeptides for extravascular administration in the treatment or prophylaxis of a blood coagulation disorder
CSL Behring Lengnau AG0 citations44